The Role of p53 in Suppression of KSHV Cyclin-induced Lymphomagenesis

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cancer Research

• Publication date

  2004-01-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-03-1863PMID 14744772
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genome-wide array CGH analysis of murine neuroblastoma reveals distinct genomic aberrations which parallel those in human tumors.

  2003cited by this paper
• Dissecting p53 tumor suppressor functions in vivo.

  2002cited by this paper
• Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice.

  2002cited by this paper
• Apoptosis Inhibitor as a Suppressor of Tumor Progression: Expression of Bcl-2 Eliminates Selective Advantages for p53-Deficient Cells in the Tumor

  2002cited by this paper
• The oncogenic potential of Kaposi's sarcoma-associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivo.

  2002influential reference
• Disruption of pre-TCR expression accelerates lymphomagenesis in E2A-deficient mice

  2002cited by this paper
• Expression of p53 and human herpesvirus‐8 (HHV‐8)–encoded latency‐associated nuclear antigen with inhibition of apoptosis in HHV‐8–associated malignancies

  2001cited by this paper
• Viral Cyclin–Cyclin-Dependent Kinase 6 Complexes Initiate Nuclear DNA Replication

  2001cited by this paper
• Novel properties of the cyclin encoded by Human Herpesvirus 8 that facilitate exit from quiescence

  2001cited by this paper
• CAK-independent activation of CDK6 by a viral cyclin.

  2001cited by this paper
• Independence of Herpesvirus-Induced T Cell Lymphoma from Viral Cyclin D Homologue

  2001cited by this paper
• Do Centrosome Abnormalities Lead to Cancer?

  2001cited by this paper
• The combination of chemotherapy and systemic immunotherapy with soluble B7-immunoglobulin G leads to cure of murine leukemia and lymphoma and demonstration of tumor-specific memory responses.

  2001cited by this paper
• Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas

  2001cited by this paper
• Cell biology. Do centrosome abnormalities lead to cancer?

  2001cited by this paper
• Managing the centrosome numbers game: from chaos to stability in cancer cell division.

  2001cited by this paper
• Human papillomavirus type 16 E7 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotype.

  2001cited by this paper
• A common E2F-1 and p73 pathway mediates cell death induced by TCR activation

  2000cited by this paper
• Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors.

  2000cited by this paper
• A role for E2F1 in the induction of apoptosis during thymic negative selection.

  2000cited by this paper
• The apoptotic v-cyclin–CDK6 complex phosphorylates and inactivates Bcl-2

  2000cited by this paper
• Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi's sarcoma and other diseases.

  2000cited by this paper
• A role for E2F1 in the induction of ARF, p53, and apoptosis during thymic negative selection.

  1999cited by this paper
• The Inhibitor of Death Receptor Signaling, Flice-Inhibitory Protein Defines a New Class of Tumor Progression Factors

  1999cited by this paper
• p53 inhibition by the LANA protein of KSHV protects against cell death

  1999cited by this paper
• Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.

  1999cited by this paper
• Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus.

  1999cited by this paper
• The Murine Gammaherpesvirus 68 v-Cyclin Gene Is an Oncogene That Promotes Cell Cycle Progression in Primary Lymphocytes

  1999cited by this paper
• Degradation of p27Kip cdk inhibitor triggered by Kaposi's sarcoma virus cyclin–cdk6 complex

  1999cited by this paper
• Modulation of p27Kip1 levels by the cyclin encoded by Kaposi's sarcoma‐associated herpesvirus

  1999cited by this paper
• The evolution of B precursor leukemia in the Emu-ret mouse.

  1998cited by this paper
• The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2

  1998cited by this paper
• Evidence for multiclonality in multicentric Kaposi's sarcoma.

  1998cited by this paper
• Human herpes virus 8 (HHV-8) in Kaposi's sarcoma: lack of association with Bcl-2 and p53 protein expression.

  1998cited by this paper
• p14ARF links the tumour suppressors RB and p53

  1998cited by this paper
• The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.

  1998cited by this paper
• The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1

  1997influential reference
• Genomic instability and apoptosis are frequent in p53 deficient young mice

  1997cited by this paper
• Regulation of p53 stability by Mdm2

  1997cited by this paper
• Mdm2 promotes the rapid degradation of p53

  1997cited by this paper
• Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins

  1997cited by this paper
• Complete sequence and genomic analysis of murine gammaherpesvirus 68

  1997cited by this paper
• KSHV and Kaposi's sarcoma: the end of the beginning?

  1997cited by this paper
• Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin

  1997cited by this paper
• Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).

  1996cited by this paper
• Cyclin encoded by KS herpesvirus

  1996influential reference
• An immunohistochemical study of p53 protein expression in classical Kaposi's sarcoma.

  1996cited by this paper
• Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

  1995cited by this paper
• Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.

  1995cited by this paper
• Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

  1994cited by this paper
• Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene.

  1994cited by this paper
• Identification of G1 kinase activity for cdk6, a novel cyclin D partner

  1994cited by this paper
• Cyclin D1/bcl‐1 cooperates with myc genes in the generation of B‐cell lymphoma in transgenic mice.

  1994cited by this paper
• p53 is required for radiation-induced apoptosis in mouse thymocytes

  1993cited by this paper
• Thymocyte apoptosis induced by p53-dependent and independent pathways

  1993cited by this paper
• Spontaneous and carcinogen–induced tumorigenesis in p53–deficient mice

  1993cited by this paper
• Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

  1992cited by this paper
• Primary structure of the herpesvirus saimiri genome

  1992cited by this paper
• A histologic and flow cytometric study of Kaposi's sarcoma

  1992cited by this paper
• Induction of apoptosis in fibroblasts by c-myc protein.

  1992cited by this paper
• Spindle cell ploidy and proliferation in endemic and epidemic African Kaposi's sarcoma.

  1992cited by this paper
• Flow cytometric DNA content in Kaposi's sarcoma by histologic stage. Comparison with angiosarcoma.

  1991cited by this paper
• Formation of the tetraploid intermediate is associated with the development of cells with more than four centrioles in the elastase-simian virus 40 tumor antigen transgenic mouse model of pancreatic cancer.

  1991cited by this paper
• Preferential development of pre‐B lymphomas with drastically down‐regulated N‐myc in the Eμ‐ret transgenic mice

  1991cited by this paper
• Genetic Effects on Aging

  1990cited by this paper
• IgH enhancer deregulated expression of L‐myc: abnormal T lymphocyte development and T cell lymphomagenesis.

  1990cited by this paper
• The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells

  1988cited by this paper
• Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs.

  1985cited by this paper
• The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

  1985cited by this paper
• Introduction of a μ immunoglobulin gene into the mouse germ line: Specific expression in lymphoid cells and synthesis of functional antibody

  1984cited by this paper

• Enfermedad de Kaposi

  2026cites this paper
• Maladie de Kaposi

  2025cites this paper
• HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus

  2024cites this paper
• Mouse models of Kaposi sarcoma-associated herpesvirus (KSHV).

  2024cites this paper
• Cancers associated with human gammaherpesviruses

  2021cites this paper
• Novel Functions and Virus-Host Interactions Implicated in Pathogenesis and Replication of Human Herpesvirus 8.

  2021cites this paper
• p53 Controls Murine Gammaherpesvirus Latency and Prevents Infection-Associated IgH/c-Myc Translocations

  2020cites this paper
• The Role of the Human Virome in Hematologic Malignancies

  2019cites this paper
• In Vivo Models of Oncoproteins Encoded by Kaposi’s Sarcoma-Associated Herpesvirus

  2019cites this paper
• Human herpesvirus–encoded kinase induces B cell lymphomas in vivo

  2018cites this paper
• Rhadinoviral interferon regulatory factor homologues

  2017cites this paper
• Epidemiological aspects and origin of KSHV

  2017cites this paper
• Primary lymphocyte infection models for KSHV and its putative tumorigenesis mechanisms in B cell lymphomas

  2017cites this paper
• Kaposi sarcoma herpesvirus pathogenesis

  2017cites this paper
• Viral modulation of host cell anti-apoptotic mechanisms and cellular stress to promote viral pathogenesis

  2016cites this paper
• KSHV-Mediated Angiogenesis in Tumor Progression

  2016cites this paper
• The role of Kaposi sarcoma‐associated herpesvirus in the pathogenesis of Kaposi sarcoma

  2015cites this paper
• Classical and non-classical thyroid hormone intracellular pathways involved in T lymphoma growth

  2015cites this paper
• Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis.

  2015cites this paper
• Overexpression of Cdk6 and Ccnd1 in chondrocytes inhibited chondrocyte maturation and caused p53-dependent apoptosis without enhancing proliferation

  2014cites this paper
• Contribution of Viral Mimics of Cellular Genes to KSHV Infection and Disease

  2014cites this paper
• Gammaherpesviruses and lymphoproliferative disorders.

  2014cites this paper
• KSHV viral cyclin interferes with T-cell development and induces lymphoma through Cdk6 and Notch activation in vivo

  2014cites this paper
• Viral Cyclin promotes KSHV-induced cellular transformation and tumorigenesis by overriding contact inhibition

  2014cites this paper
• KSHV: pathways to tumorigenesis and persistent infection.

  2014cites this paper
• Cell Cycle Regulation During Viral Infection

  2014cites this paper
• Kaposi’s Sarcoma-Associated Herpesvirus: Epidemiology, Biological Characteristics and Pathogenesis

  2014cites this paper
• Kaposi’s Sarcoma-Associated Herpesvirus: Pathogenesis and Host Immune Response

  2014cites this paper
• Viral latency locus augments B-cell response in vivo to induce chronic marginal zone enlargement, plasma cell hyperplasia, and lymphoma.

  2013cites this paper
• Intrinsic Immunity

  2013cites this paper
• KSHV vGPCR: A VIRAL ONCOPROTEIN THAT TRIGGERS AUTOPHAGY AND CELLULAR SENESCENCE

  2013cites this paper
• Interplay between DNA tumor viruses and the host DNA damage response.

  2013cites this paper
• Phosphoproteomic Analyses Reveal Signaling Pathways That Facilitate Lytic Gammaherpesvirus Replication

  2013cites this paper
• How virus persistence can initiate the tumorigenesis process.

  2013cites this paper
• Combination of Arsenic and Interferon-α Inhibits Expression of KSHV Latent Transcripts and Synergistically Improves Survival of Mice with Primary Effusion Lymphomas

  2013cites this paper
• Review of latent and lytic phase biomarkers in Kaposi's sarcoma.

  2013cites this paper
• Subversion of autophagy by Kaposi's sarcoma-associated herpesvirus impairs oncogene-induced senescence.

  2012influential citation
• Cyclin-Dependent Kinase 6 Phosphorylates NF-κB P65 at Serine 536 and Contributes to the Regulation of Inflammatory Gene Expression

  2012cites this paper
• KAPOSI SARCOMA HERPESVIRUS Kaposi sarcoma herpesvirus was considered by a previous

  2012cites this paper
• iArc monogrAphs on the evAluAtion oF cArcinogenic risks to humAns

  2012cites this paper
• Virus-host cell interplay in the pathogenesis of Kaposi's sarcoma herpesvirus

  2012cites this paper
• Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients.

  2011cites this paper
• A Clinical Overview of Centrosome Amplification in Human Cancers

  2011cites this paper
• Cyclin-Cyclin-dependent Kinase Regulatory Response Is Linked to Substrate Recognition*

  2011cites this paper
• At a crossroads: human DNA tumor viruses and the host DNA damage response.

  2011cites this paper
• To reactivate or not to reactivate : Control of KSHV lytic replication is essential for apoptosis in response to p53 restoration

  2010cites this paper
• Open Access RESEARCH

  2010cites this paper
• The role of host cell factors in the lytic reactivation of Kaposi's sarcoma-associated herpesvirus from latency

  2010cites this paper
• Kaposi Sarcoma Pathogenesis: A Triad of Viral Infection, Oncogenesis and Chronic Inflammation.

  2010cites this paper
• Functional availability of gamma-herpesvirus K-cyclin is regulated by cellular CDK6 and p16INK4a.

  2010cites this paper
• Prospects of a novel vaccination strategy for human gamma-herpesviruses

  2010cites this paper
• Kaposi's sarcoma and its associated herpesvirus

  2010cites this paper
• Cyclin K and cyclin D1b are oncogenic in myeloma cells

  2010cites this paper
• Centrosome function in cancer: guilty or innocent?

  2009cites this paper
• The contribution of systems biology and reverse genetics to the understanding of Kaposi’s sarcoma-associated herpesvirus pathogenesis in endothelial cells

  2009cites this paper
• Viral transformation and aneuploidy

  2009cites this paper
• KSHV Latent Genes and Their Regulation

  2009cites this paper
• Systematic analysis of the intracellular localization of human herpesvirus 8-encoded proteins

  2009cites this paper
• Molecular Biology of Human Herpesvirus 8 Neoplasia

  2008cites this paper
• Kaposi-Sarcoma-Associated Herpesvirus

  2008cites this paper
• Newly Identified Human Herpesviruses: HHV-6, HHV-7, and HHV-8

  2007cites this paper
• Is the infection/latency/reactivation cycle of viruses an oncogenic engine?

  2007cites this paper
• Kaposi's Sarcoma-Associated Herpesvirus K-Cyclin Interacts with Cdk9 and Stimulates Cdk9-Mediated Phosphorylation of p53 Tumor Suppressor

  2007influential citation
• Kaposi sarcoma-associated herpesvirus and other viruses in human lymphomagenesis.

  2007cites this paper
• Kaposi's sarcoma: a model of both malignancy and chronic inflammation.

  2007cites this paper
• The Interplay Between KSHV-encoded Viral Cyclin and CDK-inhibitors p27Kip1 and p21Cip1 -implications for Viral Lymphomagenesis

  2007cites this paper
• The latency-associated nuclear antigen of Kaposi sarcoma-associated herpesvirus induces B cell hyperplasia and lymphoma.

  2006cites this paper
• Cell signaling pathways engaged by KSHV.

  2006cites this paper
• KSHV/HHV8‐associated primary cutaneous plasmablastic lymphoma in a patient with Castleman’s disease and Kaposi’s sarcoma

  2006influential citation
• Analysis of EphA2 expression and mutant p53 in ovarian carcinoma

  2006cites this paper
• Kaposi's Sarcoma-Associated Herpesvirus-Encoded Latency-Associated Nuclear Antigen Induces Chromosomal Instability through Inhibition of p53 Function

  2006cites this paper
• Do Truncated Cyclins Contribute to Aberrant Cyclin Expression in Cancer?

  2006cites this paper
• Pathogenesis of viral lymphomas.

  2006cites this paper
• Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders

  2006cites this paper
• Viral carcinogenesis and genomic instability.

  2006cites this paper
• Regulation of Microfilament Organization by Kaposi Sarcoma-associated Herpes Virus-cyclin·CDK6 Phosphorylation of Caldesmon*

  2005cites this paper
• The N-terminal Peptide of the Kaposi's Sarcoma-associated Herpesvirus (KSHV)-cyclin Determines Substrate Specificity*

  2005cites this paper
• Constitutively active K-cyclin/cdk6 kinase in Kaposi sarcoma-associated herpesvirus-infected cells.

  2005cites this paper
• Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular cdks.

  2005cites this paper
• Guilt by association? p53 and the development of aneuploidy in cancer.

  2005cites this paper
• Lymphatic dysfunction in transgenic mice expressing KSHV k-cyclin under the control of the VEGFR-3 promoter.

  2005cites this paper
• KSHV viral cyclin binds to p27KIP1 in primary effusion lymphomas.

  2004cites this paper
• The cell cycle and how it is steered by Kaposi's sarcoma-associated herpesvirus cyclin.

  2004cites this paper
• Regulation of growth signalling and cell cycle by Kaposi's sarcoma‐associated herpesvirus genes

  2004cites this paper
• Human tumour viruses

  year unknowncites this paper
• Cyclin-Dependent Kinase 6 Phosphorylates NF-kappa B P 65 at Serine 536 and Contributes to the Regulation of Inflammatory Gene Expression

  year unknowncites this paper